Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Achilles Therapeutics
Achilles Therapeutics
(ACHL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Mk3475
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
myeloid leukemia acute
,
myeloid leukemia
,
small cell lung carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
thoracic neoplasms
,
neoplasms
,
leukemia
,
sarcoma
,
carcinoma
,
hemangiosarcoma
,
hepatocellular carcinoma
,
liver neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
biphenotypic leukemia acute
,
lymphoid leukemia
,
renal cell carcinoma
,
kidney neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
melanoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use